Announcements Trials
Browse Landscape

Phase

Phase 1 111Phase 2 80Phase 1/2 75Phase 3 64Phase 2/3 7Phase NA 3Phase 4 2

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER 34INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Breast 1

Conditions

Leukemia, Myeloid, Acute 2Breast Neoplasms 1

Interventions

Mammography 12Radiofrequency Ablation 9Blood Specimen Collection 9Standard of Care 8Drug Delivery Systems 8Colonoscopy 8Uterine Myomectomy 6Robotic Surgical Procedures 6Colposcopy 6Biopsy 6Proton Therapy 5Inositol 5Cryosurgery 5Therapeutics 4Surgical Procedures, Operative 4Radiotherapy 4Leukapheresis 4Food 4Drug Therapy 4Cryotherapy 4Cisplatin 4CF regimen 4Brachytherapy 4pegylated granulocyte colony-stimulating factor 3exemestane 3epigallocatechin gallate 3Uterine Artery Embolization 3Sunitinib 3Paclitaxel 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Injections × Clear all
NCT06765590 2026-03-09

Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer

Sichuan Huiyu Pharmaceutical Co., Ltd

Phase NA Recruiting
24 enrolled
Breast

Breast Neoplasms

NCT05801835 2023-09-21

A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Phase NA Unknown
36 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04920500 2021-06-09

Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Phase NA Unknown
16 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡